11 Jan 2019 Research

Leukaemia: Investigating stem cells to prevent cancer

What is this research looking at?

The development of effective treatments to prevent and eradicate leukaemia requires a better understanding of the mechanisms behind malignant (harmful) transformation and disease persistence during therapy.

Importantly, leukaemia development is associated with the acquisition of abnormal metabolic features, making cancer metabolism an attractive target for new therapeutic strategies.

Metabolism is closely associated to cell functions in normal and abnormal (malignant) tissues. By measuring metabolic heterogeneity in normal tissue (haemopoietic stem cells) and in cancer (leukaemia), I will determine whether distinct cell metabolic states are functionally connected to their potential for malignant transformation and therapy resistance.

I will test if malignant transformation and therapy resistance can be prevented or attenuated by targeting their metabolic dependencies. Results from the proposed research may lead to the development of new strategies for leukaemia eradication and prevention.

What could this mean for people with leukaemia?

This project investigates the metabolic features of stem cells in a bid to find out how to prevent them turning cancerous and to reduce resistance to treatment – this may lead to the development of new strategies for leukaemia eradication and prevention.

Related posts

Percy & Nell says Pants to Leukaemia with bespoke charity collaboration

14 March 2023

Percy & Nell says Pants to Leukaemia with bespoke charity collaboration

Independent clothing brand Percy & Nell has produced a unique range of sweatshirts, t-shirts, beanies​ and tote bags​, with all profits going to Leukaemia UK. The collaboration comes off the…

Widespread coverage of new leukaemia therapy shows promise in first trial patient

12 December 2022

Widespread coverage of new leukaemia therapy shows promise in first trial patient

As you may have seen in the news over the weekend, a clinical trial investigating a new leukaemia treatment has shown promising results. As part of the trial, funded by…

Leukaemia UK appoints new Director of Communications job share from Shelter to lead their ambitious strategy

31 October 2022

Leukaemia UK appoints new Director of Communications job share from Shelter to lead their ambitious strategy

Blood cancer research charity, Leukaemia UK, has hired Anna Wilson and Lizzie Afonso from housing and homelessness charity, Shelter, to job-share its new Communications Director role. This is the first…

John Goldman Fellowships for 2023 now open

5 December 2022

John Goldman Fellowships for 2023 now open

Leukaemia UK is delighted to announce that we are funding more ground-breaking research in 2023, by continuing our investment in early career scientists and clinicians for our prestigious John Goldman…